Literature DB >> 20555320

Renal CD14 expression correlates with the progression of cystic kidney disease.

Juling Zhou1, Xiaosen Ouyang, Xiangqin Cui, Trenton R Schoeb, Lesley E Smythies, Martin R Johnson, Lisa M Guay-Woodford, Arlene B Chapman, Michal Mrug.   

Abstract

Monocyte and macrophage markers are among the most highly overexpressed genes in cpk mouse kidneys with severely progressive renal cystic disease. We show here that one of these markers, CD14, is abnormally transcribed, activated and shed in cystic kidneys. However, these abnormalities were not associated with an increased number of interstitial CD14-positive mononuclear cells. Instead, we found that most non-cystic and cystic renal tubular epithelia were CD14-positive; even distal nephron-derived principal cells. Cd14 was significantly overexpressed in the kidneys of 5-day-old cpk mice and further increased as the disease progressed. In the cpk model with variable rates of cystic kidney enlargement (due to an intercross of two distinct genetic backgrounds), Cd14 expression positively correlated with kidney volume, exceeding the correlation with MCP-1, an established marker of autosomal-dominant polycystic kidney disease (ADPKD). In 16 patients with ADPKD, the baseline urinary CD14 level showed some tendency to correlate with the 2-year change in total kidney volume; however, the tendency was not statistically significant. But the association was significant when the analysis was confined to males. Clearly more studies need to be done to evaluate the utility of CD14 as a marker for outcomes in ADPKD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555320      PMCID: PMC3422025          DOI: 10.1038/ki.2010.175

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  53 in total

Review 1.  The nature and identification of quantitative trait loci: a community's view.

Authors:  Oduola Abiola; Joe M Angel; Philip Avner; Alexander A Bachmanov; John K Belknap; Beth Bennett; Elizabeth P Blankenhorn; David A Blizard; Valerie Bolivar; Gundrun A Brockmann; Kari J Buck; Jean-Francoise Bureau; William L Casley; Elissa J Chesler; James M Cheverud; Gary A Churchill; Melloni Cook; John C Crabbe; Wim E Crusio; Ariel Darvasi; Gerald de Haan; Peter Dermant; R W Doerge; Rosemary W Elliot; Charles R Farber; Lorraine Flaherty; Jonathan Flint; Howard Gershenfeld; John P Gibson; Jing Gu; Weikuan Gu; Heinz Himmelbauer; Robert Hitzemann; Hui-Chen Hsu; Kent Hunter; Fuad F Iraqi; Ritsert C Jansen; Thomas E Johnson; Byron C Jones; Gerd Kempermann; Frank Lammert; Lu Lu; Kenneth F Manly; Douglas B Matthews; Juan F Medrano; Margarete Mehrabian; Guy Mittlemann; Beverly A Mock; Jeffrey S Mogil; Xavier Montagutelli; Grant Morahan; John D Mountz; Hiroki Nagase; Richard S Nowakowski; Bruce F O'Hara; Alexander V Osadchuk; Beverly Paigen; Abraham A Palmer; Jeremy L Peirce; Daniel Pomp; Michael Rosemann; Glenn D Rosen; Leonard C Schalkwyk; Ze'ev Seltzer; Stephen Settle; Kazuhiro Shimomura; Siming Shou; James M Sikela; Linda D Siracusa; Jimmy L Spearow; Cory Teuscher; David W Threadgill; Linda A Toth; Ayo A Toye; Csaba Vadasz; Gary Van Zant; Edward Wakeland; Robert W Williams; Huang-Ge Zhang; Fei Zou
Journal:  Nat Rev Genet       Date:  2003-11       Impact factor: 53.242

2.  Single-nucleotide polymorphism in the CD14 promoter and periodontal disease expression in a Japanese population.

Authors:  K Yamazaki; K Ueki-Maruyama; T Oda; K Tabeta; Y Shimada; H Tai; T Nakajima; H Yoshie; D Herawati; G J Seymour
Journal:  J Dent Res       Date:  2003-08       Impact factor: 6.116

3.  Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes.

Authors:  V Bazil; J L Strominger
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

5.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.

Authors:  A Haziot; S Chen; E Ferrero; M G Low; R Silber; S M Goyert
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

Review 6.  Autosomal dominant polycystic kidney disease.

Authors:  P A Gabow
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

7.  PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats.

Authors:  Luiz F Onuchic; Laszlo Furu; Yasuyuki Nagasawa; Xiaoying Hou; Thomas Eggermann; Zhiyong Ren; Carsten Bergmann; Jan Senderek; Ernie Esquivel; Raoul Zeltner; Sabine Rudnik-Schöneborn; Michael Mrug; William Sweeney; Ellis D Avner; Klaus Zerres; Lisa M Guay-Woodford; Stefan Somlo; Gregory G Germino
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

8.  Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion.

Authors:  E A Lynch; C A Dinarello; J G Cannon
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

9.  Renal histology in polycystic kidney disease with incipient and advanced renal failure.

Authors:  M Zeier; P Fehrenbach; S Geberth; K Möhring; R Waldherr; E Ritz
Journal:  Kidney Int       Date:  1992-11       Impact factor: 10.612

10.  The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium.

Authors: 
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

View more
  17 in total

Review 1.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  Disruption of IFT complex A causes cystic kidneys without mitotic spindle misorientation.

Authors:  Julie A Jonassen; Jovenal SanAgustin; Stephen P Baker; Gregory J Pazour
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 3.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

4.  Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors:  Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

5.  Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Authors:  Ruben Poesen; Ali Ramezani; Kathleen Claes; Patrick Augustijns; Dirk Kuypers; Ian R Barrows; Jagadeesan Muralidharan; Pieter Evenepoel; Björn Meijers; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-07       Impact factor: 8.237

Review 6.  How the Innate Immune System Senses Trouble and Causes Trouble.

Authors:  Takashi Hato; Pierre C Dagher
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 8.237

Review 7.  Sisters in arms: myeloid and tubular epithelial cells shape renal innate immunity.

Authors:  Takashi Hato; Tarek M El-Achkar; Pierre C Dagher
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-20

Review 8.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

9.  Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.

Authors:  Erin E Olsan; Jonathan D West; Jacob A Torres; Nicholas Doerr; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

Review 10.  Nephronophthisis: should we target cysts or fibrosis?

Authors:  Gisela G Slaats; Marc R Lilien; Rachel H Giles
Journal:  Pediatr Nephrol       Date:  2015-07-29       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.